OneSource Specialty Pharma Limited (NSE:ONESOURCE)
India flag India · Delayed Price · Currency is INR
1,274.30
-56.30 (-4.23%)
Feb 21, 2025, 9:15 AM IST

NSE:ONESOURCE Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2024 FY 2023
Period Ending
Dec '24 Mar '24 Mar '23
Revenue
10,9201,719387.14
Revenue Growth (YoY)
-344.07%-
Cost of Revenue
3,576852.13336.43
Gross Profit
7,345867.0650.71
Selling, General & Admin
1,878825.5749.29
Other Operating Expenses
2,561844.61808.7
Operating Expenses
6,6882,4332,215
Operating Income
656.96-1,566-2,164
Interest Expense
-1,493-853.99-401.06
Interest & Investment Income
17.6517.6514.67
Currency Exchange Gain (Loss)
-5.75-5.75-91.59
Other Non Operating Income (Expenses)
76.12-38.97-73.21
EBT Excluding Unusual Items
-748.21-2,447-2,715
Gain (Loss) on Sale of Investments
7.577.571.15
Gain (Loss) on Sale of Assets
-58.08-58.08-
Asset Writedown
-1,159-1,159-1,451
Pretax Income
-1,907-3,657-4,156
Earnings From Continuing Operations
-1,566-3,657-4,156
Earnings From Discontinued Operations
--254.68-3,842
Net Income
-1,566-3,912-7,998
Net Income to Common
-1,566-3,912-7,998
Shares Outstanding (Basic)
924240
Shares Outstanding (Diluted)
924240
Shares Change (YoY)
-4.34%-
EPS (Basic)
-16.99-94.15-200.87
EPS (Diluted)
-16.99-94.15-200.87
Free Cash Flow
--1,710-2,068
Free Cash Flow Per Share
--41.15-51.93
Gross Margin
67.26%50.43%13.10%
Operating Margin
6.02%-91.09%-558.99%
Profit Margin
-14.34%-227.53%-2066.00%
Free Cash Flow Margin
--99.45%-534.07%
EBITDA
1,500-803.03-1,507
EBITDA Margin
13.73%-46.71%-
D&A For EBITDA
842.56762.95656.8
EBIT
656.96-1,566-2,164
EBIT Margin
6.02%-91.09%-
Revenue as Reported
11,0781,761414.06
Advertising Expenses
-5.0410.44
Source: S&P Capital IQ. Standard template. Financial Sources.